📰 Phra News
Page 28 - Phra News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Phra. Real-time updates on events, politics, business and more.
March 22, 2022
GMP Unit of The University of Birmingham - for the preparation of its Dendritic Cell vaccine AccuVAC-D001M in accordance with EU GMP. This is the final step for submission to the MHRA in preparation... | March 22, 2022
March 15, 2022
The UK Government, through the Medicines and Healthcare Products Regulatory Agency (MHRA) (the medicines and medical device regulator in the United Kingdom), recently announced a consultation to change the UK clinical trial regulations.
March 15, 2022
The UK Government, through the Medicines and Healthcare Products Regulatory Agency (MHRA) (the medicines and medical device regulator in the United Kingdom), recently announced a consultation to change the UK clinical trial regulations.
March 9, 2022
The IN01 vaccine aims to improve treatment of patients suffering from colorectal cancer mutations while maximizing tolerability and progression-free...
March 7, 2022
Thailand bids to avert population crisis as birthrate crashes
March 3, 2022
For Trade and Medical Media Only Rezafungin is a next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections, such as invasive candidiasis
February 28, 2022
SAMUT PRAKAN: An elderly woman and her 9-month-old grandson were killed and her daughter injured when their motorcycle was hit from behind by a pickup in Phra Pradaeng district early Sunday night, police said.
February 27, 2022
UK-based UnifAI Technology, developers of an app which can read COVID-19 lateral flow diagnostic tests from smartphones, has been given special use authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA). Click to read more...
February 23, 2022
Separate the food and rent payments if you are staying in a PG to claim the tax deduction on the rent
February 22, 2022
-- MHRA grants permission for UK clinical trials for AI-discovered drug combination that reduces length and severity of symptoms and could lower hospitalizations -- -- Approval expands Skymount Medical's